Home › Companies › BIOMARIN PHARMACEUTICAL INC. › 2024-2025
Compiled from SEC Form N-PX filings and BIOMARIN PHARMACEUTICAL INC.’s Form 8-K, filed May 22, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 20, 2025: 13 items on BIOMARIN PHARMACEUTICAL INC.’s Form 8-K, filed May 22, 2025: 10 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore BIOMARIN PHARMACEUTICAL INC. in the interactive database Compare manager voting policies
These tallies are BIOMARIN PHARMACEUTICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 22, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Elizabeth M. Anderson | 160,575,395 | 5,338,859 | 261,996 | -- | 10,064,270 | 97% | Elected | — |
| Elect Director: Barbara W. Bodem | 164,230,278 | 1,033,669 | 912,303 | -- | 10,064,270 | 99.3% | Elected | — |
| Elect Director: Athena Countouriotis | 163,915,734 | 1,656,229 | 604,287 | -- | 10,064,270 | 99% | Elected | — |
| Elect Director: Willard Dere | 163,380,097 | 2,536,182 | 259,971 | -- | 10,064,270 | 98% | Elected | — |
| Elect Director: Mark J. Enyedy | 164,211,417 | 1,412,156 | 552,677 | -- | 10,064,270 | 99.1% | Elected | — |
| Elect Director: Alexander Hardy | 164,875,088 | 1,051,826 | 249,336 | -- | 10,064,270 | 99.3% | Elected | — |
| Elect Director: Maykin Ho | 164,039,826 | 1,878,694 | 257,730 | -- | 10,064,270 | 99% | Elected | — |
| Elect Director: Robert J. Hombach | 163,224,408 | 2,694,927 | 256,915 | -- | 10,064,270 | 98% | Elected | — |
| Elect Director: Richard A. Meier | 160,566,321 | 5,338,585 | 271,344 | -- | 10,064,270 | 97% | Elected | — |
| Elect Director: Timothy P. Walbert | 165,166,799 | 662,209 | 347,242 | -- | 10,064,270 | 99.6% | Elected | — |
| 2. Ratification of the Selection of Independent Registered Public Accounting Firm The ratification of the selection of KPMG LLP as BioMarin's independent registered public accounting firm for the fiscal year ending December 31, 2025, as set forth in the Proxy | 168,601,089 | 7,442,009 | 197,422 | -- | -- | 96% | Approved | — |
| 3. Advisory Vote on the Compensation of Named Executive Officers The advisory (non-binding) vote to approve the compensation of BioMarin's named executive officers, as set forth in the Proxy Statement, received the following votes | 155,351,652 | 10,227,321 | 597,277 | -- | 10,064,270 | 94% | Approved | — |
| 4. Approval of an Amendment to the 2017 Equity Incentive Plan The approval of the Plan Amendment received the following votes | 157,280,864 | 7,747,768 | 1,147,618 | -- | 10,064,270 | 95% | Approved | — |
Source: BIOMARIN PHARMACEUTICAL INC., Form 8-K, filed with the SEC on May 22, 2025 — read the filing on EDGAR.
Each item below shows how the 546 asset managers that disclosed a BIOMARIN PHARMACEUTICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Alexander Hardy
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Alexander Hardy”): 164,875,088 for, 1,051,826 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 89,018,731 for, 6,597 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Athena Countouriotis
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Athena Countouriotis”): 163,915,734 for, 1,656,229 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,984,961 for, 40,367 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Barbara W. Bodem
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Barbara W. Bodem”): 164,230,278 for, 1,033,669 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,990,080 for, 35,248 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Elizabeth M. Anderson
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Elizabeth M. Anderson”): 160,575,395 for, 5,338,859 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,387,892 for, 637,436 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,236 | 1 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 0 | 488,764 | 0 | 0 | Against |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 353,795 | 5,628 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 110,269 | 81,174 | 0 | 0 | Mixed |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Mark J. Enyedy
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Mark J. Enyedy”): 164,211,417 for, 1,412,156 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,990,080 for, 35,248 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Maykin Ho
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Maykin Ho”): 164,039,826 for, 1,878,694 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 89,000,723 for, 24,605 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Richard A. Meier
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Richard A. Meier”): 160,566,321 for, 5,338,585 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,008,625 for, 1,016,703 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,150,431 | 1,806 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,099,903 | 97 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 0 | 843,433 | 0 | 0 | Against |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Robert J. Hombach
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Robert J. Hombach”): 163,224,408 for, 2,694,927 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,981,620 for, 43,708 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Timothy P. Walbert
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Timothy P. Walbert”): 165,166,799 for, 662,209 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 89,015,130 for, 10,198 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Willard Dere
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Willard Dere”): 163,380,097 for, 2,536,182 against, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors Based on the votes set forth above, BioMarin's stockholders elected each of the ten nominees set forth above to serve as a director of BioMarin until the next annual meeting of stockholders and until his or her successor is duly elected and qualified, or, if sooner…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 131 asset managers below reported 88,981,620 for, 43,708 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,237 | 0 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,100,000 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Combines 6 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended.
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“4. Approval of an Amendment to the 2017 Equity Incentive Plan The approval of the Plan Amendment received the following votes”): 157,280,864 for, 7,747,768 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, BioMarin's stockholders approved the Plan Amendment.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of BIOMARIN PHARMACEUTICAL INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 137 asset managers below reported 88,031,165 for, 728,548 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,152,236 | 1 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,099,903 | 97 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 0 | 447,463 | 0 | 0 | Against |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
| Nationwide | 162,879 | 0 | 0 | 0 | For |
Showing the 25 largest of 137 asset managers. See all 137 in the interactive database.
Combines 13 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“3. Advisory Vote on the Compensation of Named Executive Officers The advisory (non-binding) vote to approve the compensation of BioMarin's named executive officers, as set forth in the Proxy Statement, received the follo”): 155,351,652 for, 10,227,321 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, BioMarin's stockholders approved, on an advisory basis, the compensation of BioMarin's named executive officers, as set forth in the Proxy Statement.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,149,793 | 2,444 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,097,689 | 2,311 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 0 | 843,433 | 0 | 0 | Against |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Fund voting reports, all 128 managers: 87,875,091 for, 1,107,142 against, 66,717 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 17,067,608 | 0 | 0 | 0 | For |
| Dodge & Cox | 14,172,833 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 10,588,163 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 9,147,555 | 0 | 0 | 0 | For |
| BlackRock | 8,919,928 | 16,657 | 0 | 0 | For |
| State Street | 7,749,968 | 74,178 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,364,050 | 0 | 0 | 0 | For |
| Charles Schwab | 1,620,334 | 0 | 0 | 0 | For |
| Northern Trust | 1,371,304 | 16,832 | 0 | 0 | For |
| AQR | 1,328,233 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,239,265 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 1,136,224 | 0 | 0 | 0 | For |
| JPMorgan | 1,093,699 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 1,089,304 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 1,062,067 | 0 | 0 | 0 | For |
| DnB Asset Management AS | 1,001,675 | 0 | 0 | 0 | For |
| Nuveen | 0 | 953,511 | 0 | 0 | Against |
| Goldman Sachs | 801,797 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 798,699 | 0 | 0 | 0 | For |
| Vanguard | 759,441 | 0 | 0 | 0 | For |
| Aberdeen | 751,147 | 0 | 0 | 0 | For |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 647,217 | 0 | 0 | 0 | For |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 0 | 623,928 | 0 | 0 | Against |
| Citadel | 616,550 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 607,862 | 0 | 0 | Against |
Institutional-manager reports, all 457 managers: 103,732,252 for, 7,626,967 against, 453,532 abstained, 4,165 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.
BIOMARIN PHARMACEUTICAL INC.’s own tally for this item (“2. Ratification of the Selection of Independent Registered Public Accounting Firm The ratification of the selection of KPMG LLP as BioMarin's independent registered public accounting firm for the fiscal year ending Decem”): 168,601,089 for, 7,442,009 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, BioMarin's stockholders ratified the selection of KPMG LLP as BioMarin's independent registered public accounting firm to serve for the year ending December 31, 2025.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of BIOMARIN PHARMACEUTICAL INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, 1,350 for, 30,169 against).
The 130 asset managers below reported 88,959,651 for, 35,508 against, 66,717 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 32,150,430 | 1,807 | 0 | 0 | For |
| BlackRock | 12,596,604 | 0 | 0 | 0 | For |
| Dodge & Cox | 11,525,325 | 0 | 0 | 0 | For |
| Capital Group | 8,669,069 | 0 | 0 | 0 | For |
| Fidelity | 3,339,881 | 0 | 0 | 0 | For |
| State Street | 3,099,809 | 191 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,994,376 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,813,621 | 0 | 0 | 0 | For |
| Charles Schwab | 1,505,451 | 0 | 0 | 0 | For |
| TIAA | 843,433 | 0 | 0 | 0 | For |
| Aberdeen | 721,531 | 0 | 0 | 0 | For |
| First Trust | 664,902 | 0 | 0 | 0 | For |
| Capitol Series Trust | 547,000 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 517,507 | 0 | 0 | 0 | For |
| Dimensional | 488,764 | 0 | 0 | 0 | For |
| JPMorgan | 455,486 | 0 | 0 | 0 | For |
| American Century | 447,463 | 0 | 0 | 0 | For |
| Equitable | 381,070 | 0 | 0 | 0 | For |
| Jackson National | 359,423 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 289,881 | 0 | 0 | 0 | For |
| Empower | 246,899 | 0 | 0 | 0 | For |
| AQR | 236,403 | 0 | 0 | 0 | For |
| Goldman Sachs | 218,905 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 212,188 | 0 | 0 | 0 | For |
| John Hancock | 191,443 | 0 | 0 | 0 | For |
Showing the 25 largest of 130 asset managers. See all 130 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of May 21, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 191,755,802 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 16.77% |
| 2 | BlackRock | 6.57% |
| 3 | Dodge & Cox | 6.01% |
| 4 | Capital Group | 4.52% |
| 5 | Fidelity | 1.74% |
| 6 | State Street | 1.62% |
| 7 | PRIMECAP Odyssey Funds | 1.56% |
| 8 | Columbia Threadneedle | 1.47% |
| 9 | Charles Schwab | 0.79% |
| 10 | TIAA | 0.44% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PRIMECAP MANAGEMENT CO/CA/ | 8.90% |
| 2 | Dodge & Cox | 7.39% |
| 3 | VIKING GLOBAL INVESTORS LP | 5.52% |
| 4 | Capital Research Global Investors | 4.77% |
| 5 | BlackRock | 4.66% |
| 6 | State Street | 4.08% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.75% |
| 8 | Charles Schwab | 0.85% |
| 9 | Northern Trust | 0.72% |
| 10 | AQR | 0.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| The Vanguard Group | 9.90% | DEF14A |
| BlackRock, Inc. | 9.16% | 13G |
| PRIMECAP MANAGEMENT CO/CA/ | 8.24% | 13G |
| Dodge & Cox | 7.30% | DEF14A |
| Vanguard Capital Management | 5.27% | 13G |
| Entities affiliated with Viking Global Investors LP | 5.09% | DEF14A |
| Capital Research Global Investors | 4.77% | 13G |
| State Street | 4.41% | 13F |
| VIKING GLOBAL INVESTORS LP | 4.34% | 13G |
| Norges Bank | 1.81% | 13F |
Percentages above are of 191,755,802 shares outstanding, as reported by BIOMARIN PHARMACEUTICAL INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOMARIN PHARMACEUTICAL INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At BIOMARIN PHARMACEUTICAL INC.'s shareholder meeting held May 20, 2025, in the 2024-2025 proxy season, 546 asset managers reported how they voted on 13 ballot items in their SEC Form N-PX filings, covering 7,300 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — BIOMARIN PHARMACEUTICAL INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIOMARIN PHARMACEUTICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 22, 2025.
BIOMARIN PHARMACEUTICAL INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.